Table 1 Characteristics of glioblastoma patients in our multi-center study cohorts
From: Uncertainty-aware ensemble of foundation models differentiates glioblastoma from its mimics
Glioblastoma | |||||
|---|---|---|---|---|---|
Age (mean ± sd) | BWH N = 104 | UPenn N = 88 | Vienna N = 511 | TVGH N = 358 | Mayo N = 166 |
63.18 ± 12.63 | 51.89 ± 26.91 | 61.30 ± 12.07 | 53.86 ± 17.03 | 49.13 ± 15.70 | |
Sex | |||||
Male | 60 | 53 | 305 | 205 | 100 |
Female | 44 | 31 | 206 | 153 | 66 |
Unknown | – | 4 | – | – | – |
Race | |||||
White | 93 | 69 | 509 | – | 125 |
Black or African American | 1 | 3 | – | – | 1 |
Asian | 2 | 4 | 2 | 358 | 8 |
Hispanic or Latino | – | – | – | – | – |
Other races | 4 | – | – | – | – |
Not available | 4 | 12 | – | – | 32 |
Genomic profiles | |||||
MGMT hypermethylation among glioblastoma patients | |||||
MGMT (+) | 30 | 35 | 30 | – | 30 (excluding 7 with intermediate methylation level) |
MGMT (−) | 14 | 51 | 45 | – | 36 |
Not specified | 60 | 2 | 436 | 358 | 93 |
